What is Cdsco in pharmacovigilance?

the central drugs standard control organization (cdsco), being the apex regulatory authority for approval of drugs in india, is committed to safeguard and enhance the Public health by assuring the safety, efficacy and quality of drugs, cosmetics and medical devices.

What are the ICH guidelines for pharmacovigilance?

The following principles underpin this guideline: • Planning of pharmacovigilance activities throughout the product life-cycle; • Science-based approach to risk documentation; • Effective collaboration between regulators and industry; • Applicability of the Pharmacovigilance Plan across the three ICH regions.

How do you define pharmacovigilance?

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem. All medicines and vaccines undergo rigorous testing for safety and efficacy through clinical trials before they are authorized for use.

What is Cdsco function?

Central Drugs Standard Control Organization (CDSCO) exercises regulatory control over the quality of drugs, cosmetics and notified medical devices in the country. • It is the Central Drug Authority for discharging functions assigned to the Central Government under the Drugs and Cosmetics Act.

What is the role of Cdsco?

Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring …

Which of the trial phase is for pharmacovigilance?

Phase 4. Post marketing surveillance involves monitoring for safety (pharmacovigilance) once a treatment has been approved by the appropriate regulatory authority or authorities.

What is the full form of Cdsco?

The Central Drugs Standard Control Organisation(CDSCO)under Directorate General of Health Services,Ministry of Health & Family Welfare,Government of India is the National Regulatory Authority (NRA) of India.

What is rule 122 DAC in clinical trials?

Rule 122 DAC -Conditions of permission for conduct of clinical trial which includes mandatory requirement to follow Good Clinical Practice (GCP) guidelines, guidelines and requirements specified in Schedule Y of Drugs and Cosmetics Rules and other applicable regulations.

What is Indian Pharmacopoeia Commission doing to promote safety of medical devices?

Indian Pharmacopoeia Commission is hosting an event to formally launch various tools to promote safety of Medical Devices on February 8, 2019 from 11.00 am to 1.00 pm The National Coordination Centre (NCC)-Materiovigilance Programme of India (MvPI) has released Draft Guidance Document for Medical Devices.

What is mvpi draft guidance document for medical devices?

The National Coordination Centre (NCC)-Materiovigilance Programme of India (MvPI) has released Draft Guidance Document for Medical Devices. This is a unique document which covers all the relevant information related to Medical Device under one umbrella.